Document Detail


Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation activation after cardiac arrest.
MedLine Citation:
PMID:  11436524     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombolysis is an effective causal therapy for patients suffering from massive pulmonary embolism or acute myocardial infarction. In more than 70% of patients with cardiac arrest, one of these two diseases is the underlying cause of deterioration. Nevertheless, because of the fear of severe bleeding complications, thrombolytic therapy during cardiopulmonary resuscitation (CPR) has been contraindicated. Increasing clinical experience and data from open studies now suggest that thrombolysis during CPR can contribute to hemodynamic stabilization and survival in patients with massive pulmonary embolism and acute myocardial infarction, after conventional CPR procedures have been performed unsuccessfully. After administration of thrombolytic agents, some patients have been stabilized even after more than 90 minutes of CPR. Besides the specific causal action of thrombolytic agents at the site of pulmonary emboli and coronary thrombosis, experimental data indicate that thrombolysis during CPR can improve microcirculatory reperfusion, which may be most important in the brain. In accordance with these data, marked activation of blood coagulation without adequate activation of endogenous fibrinolysis has been demonstrated during reperfusion after cardiac arrest. Massive coagulation activation with subsequent fibrin formation is responsible for microcirculatory reperfusion disorders, and thrombolytic therapy may be indicated. However, no controlled studies are available on this therapeutic concept. Because the risk of bleeding complications is potentially associated with the administration of thrombolytic agents, although this occurs far less than anticipated, thrombolysis during CPR is presently a treatment strategy that can be performed on an individual basis. Whether thrombolysis during CPR can improve survival rates and neurologic outcomes should be addressed in randomized, controlled trials.
Authors:
B W Böttiger; E Martin
Related Documents :
2513714 - Risks versus benefits: the alteplase experience.
16911924 - Successful thrombolytic therapy for bilateral renal infarction: a case report.
12487044 - Thrombolysis for acute myocardial infarction in australasia 1999.
8070154 - Forearm compartment syndrome following thrombolytic therapy for acute myocardial infarc...
9857934 - Troponin t or troponin i or ck-mb (or none?).
6504864 - Prognostic importance of cholesterol levels after myocardial infarction.
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  Current opinion in critical care     Volume:  7     ISSN:  1070-5295     ISO Abbreviation:  Curr Opin Crit Care     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-07-04     Completed Date:  2001-12-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9504454     Medline TA:  Curr Opin Crit Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  176-83     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, University of Heidelberg, Im Neuenheimer Feld 110, D-69120 Heidelberg, Germany. bernd_boettiger@med.uni-heidelberg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Coagulation*
Brain / blood supply
Cardiopulmonary Resuscitation*
Emergency Medical Services
Heart Arrest / drug therapy*,  physiopathology
Humans
Reperfusion
Thrombolytic Therapy*
United States

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mechanical advances in cardiopulmonary resuscitation.
Next Document:  Therapeutic hypothermia after cardiac arrest.